FT : Deloitte under investigation over audit of Essar Oil UK

Deloitte under investigation over audit of Essar Oil UK
Review by ICAEW of governance disclosures is latest blow to Big Four accountancy group

Deloitte is under investigation over its auditing of Essar Oil UK, the owner of the Stanlow oil refinery that produces 16 per cent of the fuel used on British roads.

Prompted by a complaint in August, the Institute of Chartered Accountants in England and Wales has begun examining whether Deloitte should have raised its concerns about Essar Oil UK’s governance earlier than it did, according to documents seen by the Financial Times.

Deloitte resigned as auditor in October 2020, citing governance concerns affecting Essar Oil UK’s audit strategy. It did not raise such concerns three months earlier when it signed off the company’s accounts for the 18 months to September 2019.

The investigation is the latest UK audit inquiry into Deloitte, which was fined a record £15m last year for serious misconduct in its audit of software group Autonomy.

The Big Four group, which paid its partners more than £1m on average last year, is the subject of separate investigations over its audits of UK outsourcer Mitie Group and building materials company SIG.

The ICAEW is also examining whether Deloitte breached a statutory deadline for publicly filing reasons for its resignation at Companies House. In addition, it is scrutinising how the accounting group dated documents when it did file them almost six months after it resigned.

An auditor resigning over governance concerns is generally required under English law to file a statement of reasons at Companies House within 28 days. Failure to do so may be an offence under the Companies Act.

Deloitte initially filed its statement in November 2020 but it was found unacceptable and was returned, according to a Companies House response to a freedom of information request, seen by the FT.

The correctly filed statement, now available publicly, was not sent to Companies House until April 2021, almost six months after Deloitte resigned. The filing followed reports that Essar Oil UK was in talks to secure new funding and concern among Whitehall officials about the company’s future.

Deloitte said in the statement that “improvements are required to both the control and the governance framework of [Essar Oil UK], in particular regarding loans and advances, in order for the audit strategy to be effective”.

The ICAEW is investigating whether the accounting firm should have disclosed its concerns in its report on the 2019 accounts, as it may have been “aware of matters that impacted on the effectiveness of the audit strategy”, the documents seen by the FT show.

An ICAEW case manager wrote that “given the contents and timing of the resignation statement [relative] to the audit report issued I do have some potential concerns regarding the audit report issued”.

During the period between Deloitte’s resignation in October 2020 and its completion of the filings in April 2021 Essar Oil UK moved to refinance, as demand for fuel slumped because of the pandemic and Lloyds Banking Group terminated a loan facility.

The delay meant potential lenders and other stakeholders such as suppliers may have been unaware of Deloitte’s statement about Essar Oil UK’s governance framework.

“The deadline is there for a very good reason which is that the world deserves to know if an auditor has [resigned over governance concerns affecting the audit strategy],” said Paul Lee, head of stewardship and sustainable investment strategy at investment consultant Redington.

Essar Oil UK, part of an Indian conglomerate, later said it had agreed a payment schedule with HMRC, improved its liquidity and governance and that trading had improved.

The complaint falls to the ICAEW rather than the Financial Reporting Council because Essar is a private company. The documents seen by the FT showed investigators had not yet decided whether to refer the matter to the ICAEW’s investigation committee, which has the power to launch disciplinary proceedings.

The ICAEW said its rules prevented it from commenting on whether any matter is under investigation unless disciplinary action is taken.

The professional body’s case manager said in a document seen by the FT that if Deloitte’s original filing was sent within the time limit then “it is not considered there would be a breach that would require reporting”.

She did not state how long the ICAEW considered a reasonable amount of time to properly complete a filing after the initial version was rejected by Companies House.

Deloitte, which declined to comment, was replaced as auditor of Essar Oil UK by PKF Littlejohn, a midsized firm that took over the audit of retailer Boohoo last year after PwC resigned. Deloitte declined to comment.

Essar said: “Deloitte gave [Essar Oil UK] a clean audit opinion in July 2020, as did a separate independent auditor in 2021.”

The company “has taken extensive action to address the governance concerns raised by Deloitte more than a year earlier, including the appointment of an additional independent director and a commitment to the Wates Corporate Governance Principles”, and its current governance structure is above market standards for a private company, it added.

FT : Chubb to buy Cigna’s Asian and Turkey businesses for $6bn

Chubb to buy Cigna’s Asian and Turkey businesses for $6bn
US group says acquisition will expand region’s share of its global portfolio to 20%

Chubb has agreed to pay $5.75bn for the life insurance and accident and health insurance businesses of Cigna in the Asia-Pacific region and in Turkey in the US group’s latest move to expand in the region.

Chubb said the purchase would increase Asia’s share of its global portfolio from $4bn to $7bn in premiums, or about 20 per cent of the company’s total, excluding mainland China.

Chubb has expanded in recent years through a string of acquisitions that have made it into the largest US non-life insurer by market value.

In 2018 it paid $2.1bn for commercial insurance specialist Navigator. In April this year it offered to buy industry rival Hartford in a deal that valued it at $25bn, but was rebuffed.

It has also sought to expand its interests in China, increasing its stake in its joint insurance venture in the country and signalling that it wanted majority control in 2019.

Chubb said on Friday it planned to take over the “life and non-life insurance companies that house the personal accident, supplemental health and life insurance business” of Cigna in South Korea, Taiwan, Hong Kong, Thailand, New Zealand and Indonesia, as well as its controlling interest in a joint venture in Turkey.

Chubb said it expected the purchase to increase operating income per share by 6 per cent for the full year and to increase return on equity by 0.55 per cent by 2023.

“The addition of Cigna’s business, which is overwhelmingly A&H, will further balance our global portfolio toward this important region,” said Evan Greenberg, chair and chief executive.

Chubb said the deal would require local regulatory approval but would not be subject to a shareholder vote.

It expected the acquisition of Cigna’s South Korean company, which would continue to operate under its local brand name, to conclude next year with the rest of the companies to follow later in 2022.

Cigna said it expected to realise net proceeds of $5.4bn after tax from the sale, which it planned to use primarily for share repurchases. The sale would help Cigna to focus on its health insurance operations, chief executive David Cordani said.

“Cigna will continue to operate its robust international health businesses for the globally mobile population, as well as local market services in the Middle East, Europe, Hong Kong, Singapore and its joint ventures in Australia, China and India,” Cigna added in a statement.

The all-cash deal would not affect any share repurchase plans or its annual dividend, Chubb said.

>>> Stoxx 600 Pre-Market Indications

  • TUI (TUI1 TH) +3.4%
    • Watch European Travel Stocks as U.K. Confirms Cut to Red List
  • Equinor (DNQ TH) +2.4%
    • Norway’s Top Oil Producer Has Multibillion-Dollar Hydrogen Plan
  • Rio Tinto (RIO1 TH) +2%
  • Ubisoft (UEN TH) +1.3%
  • Vivendi (VVU TH) +1.2%
    • Vivendi Raised to Buy at Citi
  • Polymetal (PM6 TH) +1.2%
  • Unilever (UNVB TH) +0.8%
  • Reckitt (3RB TH) +0.8%
  • Daimler (DAI TH) +0.7%
  • Symrise (SY1 TH) +0.7%
  • Deutsche Bank (DBK TH) -0.6%
  • Merck KGaA (MRK TH) -0.8%
  • Continental (CON TH) -0.8%
  • UniCredit (CRIN TH) -0.9%
  • Maersk (DP4B TH) -1.1%
  • TeamViewer (TMV TH) -1.1%
  • Rheinmetall (RHM TH) -1.3%
  • Taylor Wimpey (TWW TH) -1.6%
  • Prosus (1TY TH) -1.6%
  • DNB Bank (D1NC TH) -2.2%

>>> TradeGate Pre-Market Indications

DAX:
  • Symrise (SY1 TH) +0.9%
  • Daimler (DAI TH) +0.7%
  • Deutsche Post (DPW TH) +0.7%
  • Deutsche Telekom (DTE TH) +0.3%
    • Deutsche Telekom, Eutelsat Sign Broadband Distribution Agreement
  • Vonovia (VNA TH) +0.3%
    • Vonovia Acquires Option Over 13.3% Stake in Adler Group
  • Deutsche Bank (DBK TH) -0.6%
MDAX:
  • Varta (VAR1 TH) +3.4%
  • Evotec SE (EVT TH) +0.9%
    • Evotec Widens Neuroscience Cooperation With Bristol Myers Squibb
  • Thyssenkrupp (TKA TH) +0.7%
  • K+S (SDF TH) +0.5%
  • Telefonica Deutschland (O2D TH) +0.3%
  • ProSieben (PSM TH) -0.4%
SDAX:
  • Adler Group (ADJ TH) +13%
    • Vonovia Acquires Option Over 13.3% Stake in Adler Group
    • A Controversial Tycoon Sits on Adler’s $9 Billion Pile of Debt
  • flatexDEGIRO (FTK TH) +0.8%
  • PVA TePla (TPE TH) +0.7%
  • Nordex (NDX1 TH) +0.4%
  • VERBIO Vereinigte (VBK TH) -1.1%
  • Indus Holding (INH TH) -1.2%
  • Aareal Bank (ARL TH) -3.2%
    • NOTE: Stock closed 24% higher following indicative takeover offer on Thursday

>>> What to look at today - 8th of October 2021

Stocks climbed Friday aided by a rise in Chinese shares and easing concerns about the U.S. debt ceiling. Treasury yields ticked up ahead of a key American jobs report.
Japanese shares outperformed and China advanced after reopening from a long holiday. S&P 500 and Nasdaq 100 futures fluctuated in the wake of a third day of gains for U.S. stocks. The Senate voted to temporarily increase the debt ceiling, breaking a prolonged stalemate that had buffeted markets.
China’s stock gauges weathered the ongoing focus on property-sector debt woes and Beijing’s wider regulatory broadsides. Government bond futures fell as the central bank drained short-term liquidity from the banking system.
The 10-year U.S. Treasury yield reached the highest since mid-June. Investors are fretting over inflation amid a global energy crunch, and the U.S. payrolls report Friday could cement expectations that the Federal Reserve will soon start tapering bond purchases. Australian and New Zealand debt fell, the yen declined and the dollarwas steady.
US After Hours ALLO falls -37.2% on FDA decision to place hold on clinical trials; ACCD -6.7% falls on earnings; QDEL +7.9% higher on bullish guidance

Nikkei +1.79% Hang Seng -0.26% CSI +1.07% Shanghai +0.33% Shenzen +0.49%

Eur$ 1.1547 CNH 6.4518 CNY 6.4491 JPY 111.91 GBP 1.3603 CHF 0.9296 RUB 71.82 TRY 8.9046 WTI$ 79.52 +1.56% Gold 1,759 +0.19% BTC 54,125 -0.10% ETH 3,577 -1.30%

S&P +0.03% Nasdaq -0.05% EuroStoxx -0.06% FTSE -0.02% Dax -0.10% SMI -0.15%

Macro :
- U.S.-China Trade Talks: Only Modest Progress Likely

Keep an eye on :
- ADN1 GY : Adesso Offers Up to 306,679 New Shares
- ADJ GY : Vonovia Acquires Option Over 13.3% Stake in Adler Group
- ANTO LN : Debate Over Chile Mining Tax Has Moderated, Antofagasta CEO Says
- BAYN GY : Bayer, Meda Sue Apotex to Block Copies of Astepro Allergy Spray
- BICO SS : Bico Group Offers Up to SEK2b Shares, Offering of 4.25m Shares Prices at SEK480/Share
- CA FP : Carrefour Extends Commercial Partnership With Nordic Coops
- CERV IM : Cerved Says Chairman Voted Against Extraordinary Holders Meeting
- CNMV FP : Cnova Defers Raising of Funds, Pulls Guidance Given in June
- DTE GY : Deutsche Telekom, Eutelsat Sign Broadband Distribution Agreement
- EVT GY : Evotec Widens Neuroscience Cooperation With Bristol Myers Squibb
- GSK LN : Activist Elliott Presses GSK on Progress at Investor Meeting (1)
- 3472 JP : Bain Is Said to Seek $1 Billion for Japanese Hot Spring Operator
- LDO IM : Leonardo Gets EU2.4B ESG-Linked Credit Line
- LSG NO : Leroy Prelim 3Q Harvest 56,000 Metric Tons
- BMPS IM : Monte Paschi Finalizes Disputes Settlement with Fondazione MPS
- NETC DC : Netcompany Agrees to Buy Intrasoft for EU235 Million (2)
- REP SM : Repsol 3Q Estimated Production 530,000 boe/d
- STLA IM : Stellantis Is Investing $262 Million in Indiana to ‘Retain Jobs’
- SONG LN : Blackstone in Talks to Back Merck Mercuriadis’s New Music Fund
- TEF SM : *CITI LOOKS FOR INVESTORS IN TELEFONICA'S FIBER UNIT: EL CONFI
- TSLA US : Musk Says Chip and Ship Shortages Top Threats to Tesla Growth
- VNA GY : Vonovia Acquires Option Over 13.3% Stake in Adler Group
- Z01 GY : Hellman & Friedman Matches EQT’s Offer for Zooplus at EU470/Shr

>>> Europe : Brokers Upgrades & Downgrades - 8th of October 2021

>>> Up
* EnQuest Raised to Buy at Jefferies; PT 30 pence
* Handelsbanken Raised to Outperform at KBW; PT 120 kronor
* Marks & Spencer Raised to Add at Peel Hunt; PT 190 pence
* Oatly Group ADRs Raised to Overweight at JPMorgan; PT $21
* Pennon Raised to Hold at HSBC; PT 1,180 pence
* Swedbank Raised to Outperform at KBW; PT 205 kronor
* Tullow Raised to Buy at Jefferies; PT 70 pence
* United Internet Raised to Buy at LBBW; PT 38 euros
* Vivendi Raised to Buy at Citi
* Warner Music PT Raised to $53 from $46 at Morgan Stanley

>>> Down
* Cellectis ADRs Cut to Neutral at Baird; PT $10
* DEFAMA AG Cut to Accumulate at SRC Research; PT 27 euros
* Nagarro Cut to Hold at Jefferies; PT 151 euros
* Nordea Bank Cut to Market Perform at KBW; PT 115 kronor
* SEB Cut to Market Perform at KBW; PT 130 kronor
* Zur Rose Cut to Hold at Berenberg; PT 400 Swiss francs

>>> Initiation
* Acciona Energia Rated New Buy at HSBC; PT 35 euros
* EDP Renovaveis Reinstated Buy at HSBC; PT 26 euros
* Enel Rated New Outperform at RBC
* Grupo Ecoener Rated New Hold at HSBC; PT 6 euros
* J. Martins Reinstated Accumulate at Erste Group; PT 15.85 euros
* Kape Technologies Rated New Hold at Berenberg; PT 380 pence
* UMG Rated New Overweight at Morgan Stanley; PT 30 euros
* UMG Rated New Neutral at Citi; PT 24 euros

>>> Call
* Weir Cyberattack Unlikely to Hit 2022 Forecasts, Jefferies Says

>>> US Close Dow +0.98% S&P +0.83% Nasdaq +1.05% Russell +1.59%

Closing Stock Market Summary

The S&P 500 rose 0.8% on Thursday following an agreement in the Senate that would raise the debt ceiling by $480 billion and give the Treasury enough funds through Dec. 3. The Dow Jones Industrial Average (+1.0%), Nasdaq Composite (+1.1%), and Russell 2000 (+1.6%) outperformed the benchmark index.  

After Senate Minority Leader McConnell offered Democrats this pathway yesterday, Senate Majority Leader Schumer confirmed in the morning that a deal was reached with a vote expected to be held soon. Essentially, the market breathed a sigh of relief that the worst-case scenario is likely to be averted, at least for now. 

While ten of the 11 S&P 500 sectors closed higher, the market did lose some steam ahead of tomorrow's release of the September Employment Situation report. The S&P 500 also saw some resistance near the underside of its 50-day moving average (4439). 

The consumer discretionary (+1.5%), materials (+1.4%), and health care (+1.2%) sectors finished with gains over 1.0%, while the utilities sector (-0.5%) was excluded from the advance,

The Dow Jones Transportation Average (-0.3%) was another area of relative weakness amid concerns that rising fuel costs could eat into profits. WTI crude futures rose 1.1%, or $0.81, to $78.31/bbl following news that the Department of Energy doesn't plan to tap into oil reserves, contrary to prior reporting. 

The latest weekly jobless claims figures, meanwhile, showed some improvement. Initial claims decreased by 38,000 to 326,000 (consensus 340,000) while continuing claims decreased by 97,000 to 2.714 million. 

The report rekindled selling interest in the longer-end of the Treasury market, causing some curve-steepening activity. The 10-yr yield rose five basis points to 1.57% -- matching a recent high -- while the 2-yr yield increased just one basis point to 0.31%. The U.S. Dollar Index decreased 0.1% to 94.21. 

Pfizer (PFE 42.74, +0.72, +1.7%) was another positive influence after announcing it submitted a request to the FDA for emergency use authorization for its COVID-19 vaccine in children 5-11.

Reviewing Thursday's economic data:

  • Initial jobless claims for the week ending October 2 decreased by 38,000 to 326,000 (consensus 340,000) while continuing claims for the week ending September 25 decreased by 97,000 to 2.714 million.
    • The key takeaway from the report is that the drop in initial claims fits with a view that the labor market is improving along with the trend in COVID cases.
  • Consumer credit increased by $14.4 bln in August (consensus $17.0B) after increasing an upwardly revised $17.2 bln (from $17.0 bln) in July.
    • The key takeaway from the report is that the expansion in consumer credit in August was the seventh straight increase in total outstanding credit as financing conditions remained favorable with the persistence of low rates.

Looking ahead, investors will receive the Employment Situation report for September and Wholesale Inventories for August on Friday. 

  • S&P 500 +17.1% YTD
  • Russell 2000 +13.9% YTD
  • Nasdaq Composite +13.7% YTD
  • Dow Jones Industrial Average +13.6% YTD

>>> US After Hours Summary: ALLO falls -37.2% on FDA decision to place hold on c

After Hours Summary: ALLO falls -37.2% on FDA decision to place hold on clinical trials; ACCD -6.7% falls on earnings; QDEL +7.9% higher on bullish guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: QDEL +7.9% (issues Q3 guidance well above consensus estimate), DS +0.7% (guides Q3 revs slightly below dual analyst estimate)

Companies trading higher in after hours in reaction to news: EFTR +23.4% (presents new positive data for zotatifin in animal models of triple-negative breast cancer), VXRT +10.6% (oral COVID-19 vaccine candidate shown to reduce airborne transmission of SARS-CoV-2 in an animal model), RPTX +4.8% (issues statement regarding inadvertent issuance of abstract), BW +2.8% (awarded ~$10 mln contract to install ash-handling equipment), AERI +1.7% (presents overview of retina product candidates), WSM +0.9% (increases minimum hourly wage to $15/hr), SNY +0.4% (MRTX announces collaboration with SNY to evaluate adagrasib with Sanofi's investigational SHP2 inhibitor), SGMS +0.2% (wins Vermont Lottery's 10-yr gaming systems technology contract), VMW +0.2% (authorizes a new stock repurchase program worth $2 bln), PSB +0.1% (names new CFO)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: ACCD -6.7%

Companies trading lower in after hours in reaction to news: ALLO -37.2% (FDA places hold on the company's AlloCAR T clinical trials), NKTX -4% (provides updates for NKX019 and NKX101 development programs), TMC -2.8% (stock offering), NXTC -2.2% (reports preclinical data for NC410), RKLY -1.6% (stock offering), ACHR -1% (stock offering), BGNE -0.6% (receives regulatory approval in Australia for BRUKINSA), GTLS -0.5% (names new CFO), THO -0.2% (increases dividend), PRMW -0.1% (acquires Get Fresh, a water distributor in Poland), COIN -0.1% (SEC approves ETF that tracks stocks with significant bitcoin exposure, according to Business Insider)

FT : New Bank of England chief economist warns of long-lasting inflation

New Bank of England chief economist warns of long-lasting inflation
Huw Pill’s first public remarks suggest he agrees with the hawkish elements of the MPC

High levels of UK inflation could persist for longer than expected, the Bank of England’s new chief economist said, suggesting he agrees with the more hawkish elements of the Monetary Policy Committee.

“In my view, that balance of risks is currently shifting towards great concern about the inflation outlook, as the current strength of inflation looks set to prove more long-lasting than originally anticipated,” said Huw Pill, in his first public remarks since taking office last month.

Much of the recent rise in UK inflation has stemmed from the increasing costs of imported goods, as well as international commodity prices, which are expected to be temporary as supply bottlenecks in semiconductors and shipping normalise. “But the magnitude and duration of the transient inflation spike is proving greater than expected,” he argued.

Pill’s view, shared in written responses to questions from the UK Treasury committee, suggested the new chief economist could vote in favour of an early rise in interest rates.

“He has placed himself on the hawkish side of the MPC and, if we’re looking at people who might switch camps to vote for tighter policy, Pill is probably now the one to watch most closely,” said Andrew Goodwin, economist at consultancy Oxford Economics.

Markets currently expect a 15 basis point rate rise by February, with an increasing likelihood of the first increase at the December meeting. Traders are betting on interest rates rising from the current level of 0.1 per cent to 0.75 per cent by the end of 2022.

In its September policy statement, the BoE said it expected consumer price inflation to reach 4 per cent later in the year, well above the 2 per cent bank target, and to remain high for some time.

“Over recent months, inflation has surprised to the upside,” noted Pill. “The risks to the economic and inflation outlook are again clearly becoming two-sided,” he argued, adding this contrasted with previous periods when weakness in the economy “skewed risks to activity, employment and inflation to the downside.”

Monetary policy has so far been accommodative “but as the risks to the outlook become more two-sided, monetary policy decisions will become more finely balanced,” he said.

Pill’s responses were not entirely hawkish. He added that “monetary policy should seek to support a level of activity that exploits that potential as fully as possible.”

The former Goldman Sachs economist also said that non-standard policy tools, such as quantitative easing, negative interest rates and forward guidance “are here to stay”. “They have evolved to become part of the standard monetary policy armoury,” he added.

Pill suggested a review of the bank’s QE policy with a possibility of moving towards monthly flows of asset purchases as undertaken by the Federal Reserve and the European Central Bank, following sustained criticism from the BoE’s internal watchdog and the House of Lords’ Economic Affairs Committee.

He recommended such action be taken especially in response to the gilts market malfunctioning as it did at the start of the Covid-19 crisis.

“If asset purchases are intended to support market functioning in a systemically pivotal market, such as that for sovereign debt, then a more flexible and opportunistic approach focused on the flow of asset purchases may be more appropriate.”

Goodwin said it was clear that Pill wants to “deepen the BoE’s knowledge of these tools to ensure it is ready for the next crisis, rather than having to make policy on the hoof”.

“This looks like an eminently sensible approach,” said Goodwin.